ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Jeevan Scientific Technology Limited held its 28th Annual General Meeting on September 25, 2026. Shareholders approved financial results and the re-appointment of several directors.
Jeevan Scientific Technology Limited has issued a notice for its Annual General Meeting to be held on September 25, 2026.
Jeevan Scientific Technology Limited submitted its 28th Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 25, 2026.
Jeevan Scientific Technology Limited appointed Mr. Kolli Srinivas Rao as an Independent Director and re-appointed three other directors to the Board.
Jeevan Scientific Technology Limited reported no deviation or variation in the utilization of funds from its preferential allotment during the quarter ended June 30, 2026.
Jeevan Scientific Technology Ltd reported revenue from operations of ₹18.3 Cr (+81.2% YoY) and net profit of ₹0.9 Cr for Q1 FY27.
Jeevan Scientific Technology will hold a board meeting on August 13, 2026, to consider quarterly financial results and AGM-related matters.
Jeevan Scientific Technology received CDSCO approval to increase bed capacity at its Hyderabad BA/BE Study Centre. The facility will expand from 132 to 156 regular beds.
Jeevan Scientific Technology Ltd successfully completed a USFDA inspection. The inspection concluded with no observations (Zero 483s).
Jeevan Scientific Technology Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with regulatory disclosure requirements.
Jeevan Scientific completed a CDSCO inspection for adding beds to its BA/BE center. The inspection was conducted on June 24, 2026.
Jeevan Scientific Technology submitted its FY2026 Annual Secretarial Compliance Report. The filing confirms overall regulatory compliance despite minor exchange-imposed fines for administrative delays.
Jeevan Scientific Technology reported zero deviation in utilizing ₹30.74 Crore raised through preferential allotment. Funds were deployed across capital expenditure, working capital, and acquisitions.
Jeevan Scientific Technology Limited reported its audited standalone and consolidated financial results for the year ended March 31, 2026. The results were approved during a board meeting.
Jeevan Scientific Technology Ltd reported revenue from operations of ₹21.3 Cr (+110.9% YoY) and net profit of ₹1.8 Cr for Q4 FY26.
Jeevan Scientific Technology approved its audited annual results and allotted 1,61,250 shares under ESOP. The firm also granted 4,80,000 new stock options to employees.
Jeevan Scientific Technology scheduled a board meeting on May 29, 2026, to approve audited financial results. This routine meeting provides fundamental performance updates to shareholders.
Jeevan Scientific Technology Ltd submitted its annual disclosure confirming it is not identified as a Large Corporate for FY 2025-26. The company reported zero incremental borrowing and no mandatory debt issuance requirements under SEBI's Large Corporate framework.
Jeevan Scientific Technology Ltd confirmed it does not qualify as a 'Large Corporate' for FY 2026-27 under SEBI norms. The company reported outstanding borrowings of ₹11.58 Crore as of March 31, 2026, which is below the ₹1,000 Crore threshold required for the classification.
Jeevan Scientific Technology Ltd confirmed it does not meet the SEBI criteria for identification as a Large Corporate for FY 2025-26. Consequently, the company has no mandatory debt borrowing requirements or associated penalties for the period.
Jeevan Scientific Technology Ltd (BSE: 538837) submitted its initial disclosure for FY 2026-27, confirming it does not qualify as a 'Large Corporate'. The company reported outstanding borrowings of ₹11.58 Crore, falling below the ₹1,000 Crore threshold required for the classification.